HomeStock ScreenerAstec LifesciencesQuarterly Results

Astec Lifesciences Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-8 Cr
QMar 2026
Quarterly Results

In Mar 2026, Astec Lifesciences (ASTEC) reported revenue ₹161 Cr and net profit ₹-8 Cr — revenue +34.2% YoY. Compare with ASTEC fair value to assess whether the stock is under or overvalued.

ASTEC Quarterly Results — Revenue, Profit & EPS Highlights

Astec Lifesciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore ASTEC share price charts to track price trends across different timeframes.

  • Revenue of ₹161 Cr in Mar 2026 (+114.7% vs Sept 2025, +34.2% vs Mar 2025)
  • Net Profit of ₹-8 Cr in Mar 2026 (+66.7% vs Sept 2025, +50.0% vs Mar 2025)
  • EBITDA of ₹12 Cr in Mar 2026 (+300.0% vs Sept 2025)
  • Operating Margin of 6.0% in Mar 2026 (+15.0pp vs Sept 2025)
  • Earnings Per Share of ₹-3.48 in Mar 2026 (+69.3% vs Sept 2025)

Astec Lifesciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ASTEC quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 QoQ YoY
Revenue (₹ Cr) 161 75 120 92 126 114.7% 34.2%
Net Profit (₹ Cr) -8 -24 -16 -33 -16 - -
EBITDA (₹ Cr) 12 -6 6 -11 3 - -
EPS (₹) -3.48 -11.35 -8.20 -16.85 -7.04 - -
Operating Margin (%) 6.0% -9.0% 5.0% -12.0% 2.0% - -

ASTEC Share Price Trend — 1-Year Movement Across Quarterly Results

Astec Lifesciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Astec Lifesciences share price screener.

Profitability Ratios

Profit Margin -5.0%
EBITDA Margin 7.5%
Operating Margin 6.0%
ROE (Annual) -8.2%

Balance Sheet Highlights

Total Assets ₹942 Cr
Total Equity ₹391 Cr
Current Assets ₹443 Cr
Current Liabilities ₹51 Cr

Cash Flow Analysis

Operating Cash Flow ₹-8 Cr
Investing Cash Flow ₹-15 Cr
Financing Cash Flow ₹24 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹761.25
Exchange NSE
Last Updated May 27, 2026

ASTEC vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Astec Lifesciences latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹150,700.65 Cr 1480.7 3,648 584 +1.2% +13.2% 16.0% 260.2
SRF
Mar 2026
₹81,125.55 Cr 2736.8 4,557 582 +28.0% +7.2% 12.8% 139.4
Linde
Sept 2025
₹61,592.27 Cr 7259.0 650 171 +7.4% - 26.3% 362.0
Fertilisers & Chemi…
Sept 2025
₹58,928.84 Cr 923.4 1,681 21 +48.8% - 1.2% 2885.6
UPL
Mar 2026
₹55,390.17 Cr 656.2 18,513 1,294 +49.2% +18.1% 7.0% 52.2
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores